China approves its first homegrown coronavirus vaccine, developed by Sinopharm
Chinese regulators have approved the country’s first homegrown coronavirus vaccine, developed by state-owned pharmaceutical giant Sinopharm, officials announced Thursday. The approval comes a day after Sinopharm said its vaccine is 79.34% effective, citing interim analysis of Phase 3 clinical trials. China has drastically scaled up its vaccine emergency use program in recent weeks. Since December
Continue Reading